Hims, Amazon and Hers

Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. Amazon on Thursday launched the treatments through its One Medical telehealth service,
Amazon launches fixed pricing to treat conditions like hair loss. Hims & Hers stock drops 15%
Amazon announced Prime members can access new upfront pricing to treat five common conditions like erectile disfunction and men's hair loss.
Hims & Hers drops 22% on Amazon competition concerns (update)
Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment markets through its telehealth unit. Read more here.
Amazon One Medical rolls out telehealth treatment services in competition with Ro, Hims & Hers
Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care. | Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care.
BofA double downgrades Hims & Hers on Amazon competition
BofA downgraded Hims & Hers (HIMS) to Underperform from Buy with a price target of $18, down from $32. Amazon (AMZN) launched a cash-pay
Amazon One Medical launches service to compete with Hims & Hers
The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five conditions including erectile dysfunction and men’s hair loss.
Hims & Hers drops 17% as Amazon rolls out expanded telehealth service
Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 17% in morning trading Thursday after Amazon (NASDAQ:AMZN) announced it was launching an expanded pay-per-visit telehealth service,
Hims & Hers under pressure as Amazon launches rival service
Shares of Hims & Hers (HIMS) are sliding on Thursday after Amazon (AMZN) announced the launch of its Amazon One Medical Pay-per-visit
Amazon Will Start Selling Cheap Hair-Loss Drugs. It’s a Huge Threat for This Stock.
The tech company’s prices appear set to undercut the long list of competing telehealth companies that rely on aggressive ...
Amazon Gets Into the Boner Pill Business, Hims Stock Goes Limp
Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon Pharmacy.
Amazon’s telehealth platform adds low-cost plans for hair loss, skin care, and more
Amazon One Medical is expanding its telehealth services with the launch of treatment plans and medication delivery for ...
Hims & Hers’ stock tumbles on Amazon’s latest disruptive foray into healthcare
Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will ...
Yahoo Finance4h
Amazon launches lifestyle drug service as challenge to Hims & Hers
The move into lifestyle treatments is seen as a challenge to companies like Hims & Hers, which saw its stock value drop ...
Stocktwits on MSN4h
Hims & Hers Stock’s Retail Army Brushes Off Amazon Medical One’s Rival Service Even As Citi Sees Threat
Shares of Hims & Hers ($HIMS) plummeted nearly 15% on Thursday after Amazon.com, Inc. ($AMZN) launched its new Amazon One ...
Yahoo4h
Amazon is getting into the erectile dysfunction business
Hims & Hers, founded in 2017 as “Hims,” started as a platform for men to get online prescriptions for erectile ...